Skip to main content
logo
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.890
+0.080 (4.42%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Elicio Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-37.84-39.57-51.9-35.2-28.21-26.4
Depreciation & Amortization
1.141.131.181.171.060.25
Other Amortization
0.310.220.08---
Loss (Gain) From Sale of Assets
---00.110-
Stock-Based Compensation
3.272.71.451.180.580.62
Other Operating Activities
-1.062.028.170.14.540.72
Change in Accounts Payable
-3.03-0.37-3.330.021.130.03
Change in Other Net Operating Assets
-0.49-3.087.29-0.08-1.280.84
Operating Cash Flow
-37.69-36.95-37.07-32.69-22.18-23.94
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.02-0.02-0.09-0.07-0.65-0.53
Sale of Property, Plant & Equipment
--00.03--
Investing Cash Flow
-0.02-0.02-0.08-0.03-0.65-0.53

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--19.73--14.68
Long-Term Debt Issued
-9.87-10--
Total Debt Issued
-9.8719.7310-14.68
Net Debt Issued (Repaid)
-9.8719.7310-14.68
Issuance of Common Stock
38.9726.8323.147.130.080.21
Repurchase of Common Stock
----0.15--
Other Financing Activities
---0.5521.64--0.44
Financing Cash Flow
38.9736.742.3238.6121.219.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.060.050.02---
Net Cash Flow
1.21-0.235.195.89-1.63-5.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-37.71-36.97-37.16-32.76-22.83-24.46
Free Cash Flow Growth
------
Free Cash Flow Per Share
-2.17-2.41-3.04-6.48-72.26-1.60
Levered Free Cash Flow
-22.32-21.45-23.63-16.94-20.49-12.51
Unlevered Free Cash Flow
-21.64-20.96-23.42-16.28-18.24-11.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-3.51-3.453.96-0.06-0.150.87
SEC Filings: 10-K · 10-Q